Substance / Medication

Paromomycin sulfate

Overview

Clinical overview including description, indications, and evidence base is pending physician authorship or FDA SPL integration. Graph-derived relationship data is available below.

Indications & Related Conditions

Conditions associated via SNOMED clinical relationships

Administration & Protocol

Dosing, route, and treatment protocol

Administration details including route, dosing schedules, preparation instructions, and contraindications are pending physician authorship.

Monitoring & Follow-Up

Biomarkers relevant to this intervention via related conditions

No monitoring biomarkers have been mapped yet. Biomarker-intervention linkages are derived through related conditions and will expand as the knowledge graph grows.

Research Evidence

Published studies and systematic reviews

Sort:
Evaluation of bithionol as a bath treatment for amoebic gill disease caused by Neoparamoeba spp.
Florent Renee L, Becker Joy A, Powell Mark D · Vet Parasitol · 2007
PMID: 17129675RCT
Paromomycin sulfate is an effective treatment for balantidiasis in captive cynomolgus monkeys.
Nakamura Shinichiro, Itagaki Iori, Nakagawa Takahiro et al. · Exp Anim · 2019
PMID: 30814394PreclinicalFull text (PMC)
Colloidal, in vitro and in vivo anti-leishmanial properties of transfersomes containing paromomycin sulfate in susceptible BALB/c mice.
Bavarsad Neda, Fazly Bazzaz Bibi Sedigheh, Khamesipour Ali et al. · Acta Trop · 2012
PMID: 22750480Preclinical
Effect of topical liposomes containing paromomycin sulfate in the course of Leishmania major infection in susceptible BALB/c mice.
Jaafari Mahmoud R, Bavarsad Neda, Bazzaz Bibi Sedigheh Fazly et al. · Antimicrob Agents Chemother · 2009
PMID: 19223613PreclinicalFull text (PMC)

Research data from MEDLINE/PubMed

Benefits & Expected Outcomes

Benefits, expected outcomes, efficacy data, and NNT (Number Needed to Treat) are pending physician authorship and evidence review.

Risks & Side Effects

Risk profile, common and serious adverse effects, contraindications, and drug interactions are pending physician authorship.

Related Symptoms

Symptoms associated with conditions this intervention addresses

No related symptoms have been mapped yet. Symptom linkages are derived through associated conditions.

Alternatives & Comparisons

Alternative treatments, comparison data, and clinical decision support are pending physician authorship.

Medical Disclaimer

This information is for educational purposes only and does not constitute medical advice, diagnosis, or treatment. Always consult with a qualified healthcare provider regarding any medical condition or treatment plan.

Do not start, stop, or change any treatment without consulting your healthcare provider.

Quick Facts

Type
Substance / Medication
Fully Specified Name
Paromomycin sulfate (substance)
SNOMED CT
30203009
UMLS CUI
C0205881

Clinical Data

This intervention maps to 7 entities in the Healos knowledge graph.

7
Conditions
0
Biomarkers
0
Specialists
0
Symptoms

Data is sourced from SNOMED CT, UMLS, and the Healos clinical knowledge graph. Content sections marked as pending require physician authorship. Consult a healthcare provider before starting any treatment.